These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 10833417)

  • 21. Restricted replication of primary HIV-1 isolates using both CCR5 and CXCR4 in Th2 but not in Th1 CD4(+) T cells.
    Vicenzi E; Panina-Bodignon P; Vallanti G; Di Lucia P; Poli G
    J Leukoc Biol; 2002 Nov; 72(5):913-20. PubMed ID: 12429712
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development of a cell-based enzyme-linked immunosorbent assay for high-throughput screening of HIV type 1 entry inhibitors targeting the coreceptor CXCR4.
    Zhao Q; Lu H; Schols D; De Clercq E; Jiang S
    AIDS Res Hum Retroviruses; 2003 Nov; 19(11):947-55. PubMed ID: 14678601
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Different stereochemical requirements for CXCR4 binding and signaling functions as revealed by an anti-HIV, D-amino acid-containing SMM-chemokine ligand.
    Dong CZ; Kumar S; Choi WT; Madani N; Tian S; An J; Sodroski JG; Huang Z
    J Med Chem; 2005 Dec; 48(25):7923-4. PubMed ID: 16335916
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Constitutive association of cell surface CCR5 and CXCR4 in the presence of CD4.
    Wang J; Alvarez R; Roderiquez G; Guan E; Norcross MA
    J Cell Biochem; 2004 Nov; 93(4):753-60. PubMed ID: 15660419
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HIV envelope proteins differentially utilize CXCR4 and CCR5 coreceptors for induction of apoptosis.
    Yao Q; Compans RW; Chen C
    Virology; 2001 Jun; 285(1):128-37. PubMed ID: 11414813
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of CCR5-mediated infection by diverse R5 and R5X4 HIV and SIV isolates using novel small molecule inhibitors of CCR5: effects of viral diversity, target cell and receptor density.
    Willey S; Peters PJ; Sullivan WM; Dorr P; Perros M; Clapham PR
    Antiviral Res; 2005 Nov; 68(2):96-108. PubMed ID: 16157392
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Coreceptor competition for association with CD4 may change the susceptibility of human cells to infection with T-tropic and macrophagetropic isolates of human immunodeficiency virus type 1.
    Lee S; Lapham CK; Chen H; King L; Manischewitz J; Romantseva T; Mostowski H; Stantchev TS; Broder CC; Golding H
    J Virol; 2000 Jun; 74(11):5016-23. PubMed ID: 10799575
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of in vitro and in vivo HIV replication by a distamycin analogue that interferes with chemokine receptor function: a candidate for chemotherapeutic and microbicidal application.
    Howard OM; Oppenheim JJ; Hollingshead MG; Covey JM; Bigelow J; McCormack JJ; Buckheit RW; Clanton DJ; Turpin JA; Rice WG
    J Med Chem; 1998 Jun; 41(13):2184-93. PubMed ID: 9632350
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Down-regulation of CXCR4 by human herpesvirus 6 (HHV-6) and HHV-7.
    Yasukawa M; Hasegawa A; Sakai I; Ohminami H; Arai J; Kaneko S; Yakushijin Y; Maeyama K; Nakashima H; Arakaki R; Fujita S
    J Immunol; 1999 May; 162(9):5417-22. PubMed ID: 10228019
    [TBL] [Abstract][Full Text] [Related]  

  • 30. gp120 induces cell death in human neuroblastoma cells through the CXCR4 and CCR5 chemokine receptors.
    Catani MV; Corasaniti MT; Navarra M; Nisticò G; Finazzi-Agrò A; Melino G
    J Neurochem; 2000 Jun; 74(6):2373-9. PubMed ID: 10820198
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CXCR4 is a functional coreceptor for infection of human macrophages by CXCR4-dependent primary HIV-1 isolates.
    Verani A; Pesenti E; Polo S; Tresoldi E; Scarlatti G; Lusso P; Siccardi AG; Vercelli D
    J Immunol; 1998 Sep; 161(5):2084-8. PubMed ID: 9725197
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CD4-Chemokine receptor hybrids in human immunodeficiency virus type 1 infection.
    Klasse PJ; Rosenkilde MM; Signoret N; Pelchen-Matthews A; Schwartz TW; Marsh M
    J Virol; 1999 Sep; 73(9):7453-66. PubMed ID: 10438835
    [TBL] [Abstract][Full Text] [Related]  

  • 33. AMD3100, a small molecule inhibitor of HIV-1 entry via the CXCR4 co-receptor.
    Donzella GA; Schols D; Lin SW; Esté JA; Nagashima KA; Maddon PJ; Allaway GP; Sakmar TP; Henson G; De Clercq E; Moore JP
    Nat Med; 1998 Jan; 4(1):72-7. PubMed ID: 9427609
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chemokine control of HIV-1 infection.
    Mellado M; Rodríguez-Frade JM; Vila-Coro AJ; de Ana AM; Martínez-A C
    Nature; 1999 Aug; 400(6746):723-4. PubMed ID: 10466720
    [No Abstract]   [Full Text] [Related]  

  • 35. X4 HIV-1 induces neuroblastoma cell death by interference with CXCL12/CXCR4 interaction.
    Hatse S; Bridger G; de Clercq E; Schols D
    Cell Mol Biol (Noisy-le-grand); 2003; 49 Online Pub():OL443-52. PubMed ID: 14995074
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increase of R5 HIV-1 infection and CCR5 expression in T cells treated with high concentrations of CXCR4 antagonists and SDF-1.
    Gotoh K; Yoshimori M; Kanbara K; Tamamura H; Kanamoto T; Mochizuki K; Fujii N; Nakashima H
    J Infect Chemother; 2001 Mar; 7(1):28-36. PubMed ID: 11406754
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Marked increase in anti-HIV activity, as well as inhibitory activity against HIV entry mediated by CXCR4, linked to enhancement of the binding ability of tachyplesin analogs to CXCR4.
    Xu Y; Tamamura H; Arakaki R; Nakashima H; Zhang X; Fujii N; Uchiyama T; Hattori T
    AIDS Res Hum Retroviruses; 1999 Mar; 15(5):419-27. PubMed ID: 10195751
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Distinct functional sites for human immunodeficiency virus type 1 and stromal cell-derived factor 1alpha on CXCR4 transmembrane helical domains.
    Tian S; Choi WT; Liu D; Pesavento J; Wang Y; An J; Sodroski JG; Huang Z
    J Virol; 2005 Oct; 79(20):12667-73. PubMed ID: 16188969
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The simian immunodeficiency virus mnd(GB-1) strain uses CXCR4, not CCR5, as coreceptor for entry in human cells.
    Schols D; De Clercq E
    J Gen Virol; 1998 Sep; 79 ( Pt 9)():2203-5. PubMed ID: 9747729
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intracellular and surface expression of the HIV-1 coreceptor CXCR4/fusin on various leukocyte subsets: rapid internalization and recycling upon activation.
    Förster R; Kremmer E; Schubel A; Breitfeld D; Kleinschmidt A; Nerl C; Bernhardt G; Lipp M
    J Immunol; 1998 Feb; 160(3):1522-31. PubMed ID: 9570576
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.